Rocket Pharmaceuticals, Inc. (RCKT)
USD 11.74
(-1.51%)
USD 11.74
(-1.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 7.09 Million | 6.26 Million | 5.37 Million | 1.14 Million | 426 Thousand | 330 Thousand |
| Gross Profit | -7.09 Million | -6.26 Million | -5.37 Million | -1.14 Million | -426 Thousand | -330 Thousand |
| Operating Expenses | 259.65 Million | 223.84 Million | 166.24 Million | 134.3 Million | 75.9 Million | 70.97 Million |
| Selling, General and Administrative Expenses | 73.31 Million | 58.77 Million | 41.77 Million | 27.92 Million | 17.52 Million | 17.88 Million |
| Research and Development Expenses | 186.34 Million | 165.57 Million | 125.47 Million | 106.38 Million | 58.62 Million | 53.27 Million |
| Other Expenses | - | -500 Thousand | -1 Million | - | -250 Thousand | 186 Thousand |
| Cost and Expenses | 259.65 Million | 223.84 Million | 166.24 Million | 134.3 Million | 75.9 Million | 70.97 Million |
| Operating Income | -259.65 Million | -224.34 Million | -167.24 Million | -134.3 Million | -76.15 Million | -71.15 Million |
| Interest Expense | 1.87 Million | 1.9 Million | 5.88 Million | 7.54 Million | 4.78 Million | 5.23 Million |
| Income Tax Expense | - | -2.48 Million | 516 Thousand | 6.96 Million | 5.95 Million | 2.67 Million |
| Earnings before Tax | -245.59 Million | -221.86 Million | -169.06 Million | -139.7 Million | -77.27 Million | -74.51 Million |
| Net Income | -245.59 Million | -219.38 Million | -169.58 Million | -146.66 Million | -83.22 Million | -74.51 Million |
| Earnings Per Share Basic | -2.92 | -3.22 | -2.68 | -2.65 | -1.70 | -1.89 |
| Earnings Per Share Diluted | -2.92 | -3.22 | -2.68 | -2.65 | -1.70 | -1.89 |
| Weighted Average Shares Outstanding | 84 Million | 68.14 Million | 63.23 Million | 55.38 Million | 49.01 Million | 39.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 84 Million | 68.14 Million | 63.23 Million | 55.38 Million | 49.01 Million | 39.37 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -236.62 Million | -213.68 Million | -161.71 Million | -131.58 Million | -71.13 Million | -71.15 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 10.31 Million | - | - | - |
| Cost of Revenue | 2.33 Million | 2.25 Million | 5.15 Million | 7.09 Million | 1.76 Million | 1.72 Million |
| Gross Profit | -2.33 Million | -2.25 Million | 5.15 Million | -7.09 Million | -1.76 Million | -1.72 Million |
| Operating Expenses | 71.37 Million | 65.12 Million | 63.27 Million | 252.56 Million | 65.42 Million | 68.75 Million |
| Selling, General and Administrative Expenses | 26.58 Million | 21.36 Million | 21.53 Million | - | 18.58 Million | 17.37 Million |
| Research and Development Expenses | 44.79 Million | 43.76 Million | 41.74 Million | - | 46.84 Million | 51.38 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 73.71 Million | 67.37 Million | 63.27 Million | 259.65 Million | 65.42 Million | 68.75 Million |
| Operating Income | -73.71 Million | -67.37 Million | -63.27 Million | -259.65 Million | -65.42 Million | -68.75 Million |
| Interest Expense | 471 Thousand | 471 Thousand | 470 Thousand | 1.87 Million | -469 Thousand | 468 Thousand |
| Income Tax Expense | - | 1.00 | 1.62 Million | - | -1.75 Million | 3.52 Million |
| Earnings before Tax | -69.64 Million | -62.05 Million | -59.66 Million | -245.59 Million | -61.89 Million | -65.7 Million |
| Net Income | -69.64 Million | -62.05 Million | -59.66 Million | -245.59 Million | -61.89 Million | -65.7 Million |
| Earnings Per Share Basic | -0.74 | -0.66 | -0.64 | - | -0.75 | -0.82 |
| Earnings Per Share Diluted | -0.74 | -0.66 | -0.64 | - | -0.75 | -0.82 |
| Weighted Average Shares Outstanding | 93.74 Million | 93.54 Million | 93.33 Million | 84 Million | 82.63 Million | 80.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 93.74 Million | 93.54 Million | 93.33 Million | 84 Million | 82.63 Million | 80.47 Million |
| Gross Margin | - | - | 0.50 | - | - | - |
| EBIT Margin | - | - | -5.55 | - | - | - |
| Profit Margin | - | - | -5.79 | - | - | - |
| EBITDA | -71.37 Million | -65.12 Million | -57.25 Million | - | -65.42 Million | -63.5 Million |
| Earnings Before Tax Margin | - | - | -6.14 | - | - | - |
STG
3390
8069
PHT
CSIQ
MEGASTAR